Cornerstone portfolio company, Endotronix, a medical technology company providing device and digital health solutions for heart failure management, announced on January 24th, 2018, a successful first-in-human implantation of the Cordella™ Pulmonary Artery (PA) Pressure Sensor and initiation of the SIRONA First-in-Human (FIH) clinical trial.
The wireless Cordella PA Pressure Sensor, the implantable component of the Cordella™ Heart Failure (HF) System, provides PA pressure data readings that clinicians interpret to guide therapy and provide proactive HF management.
